KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
600062 China Resources Double-Crane Pharmaceutical
- 20.55
- -0.46-2.19%
Market Closed Dec 13 15:00 CST
21.36BMarket Cap15.84P/E (TTM)
20.94High20.50Low109.32KlotVolume20.94Open21.01Pre Close225.95MTurnover1.06%Turnover Ratio16.02P/E (Static)1.04BShares26.0552wk High2.10P/B21.11BFloat Cap15.5852wk Low23.11Limit Up1.03BShs Float36.03Historical High18.91Limit Down2.09%Amplitude-1.85Historical Low0.36Dividend TTM20.67Avg Price65.39KlotAsk1.74%Div YieldTTM100Lot Size41.81KlotBid
China Resources Double-Crane Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 1.18%8.55B | 1.46%5.93B | 2.26%2.84B | 6.20%10.22B | 18.02%8.45B | 18.99%5.84B | 10.11%2.77B | 5.64%9.63B | 4.11%7.16B | 6.07%4.91B |
| Operating revenue | 1.18%8.55B | 1.46%5.93B | 2.26%2.84B | 6.20%10.22B | 18.02%8.45B | 18.99%5.84B | 10.11%2.77B | 5.64%9.63B | 4.11%7.16B | 6.07%4.91B |
| Other operating revenue | ---- | -40.28%44.6M | ---- | 5.23%108.38M | ---- | 23.35%74.69M | ---- | 32.24%102.99M | ---- | 80.22%60.55M |
| Total operating cost | 3.15%7.15B | 2.82%4.9B | 1.37%2.35B | 5.12%8.71B | 16.05%6.93B | 18.32%4.77B | 10.22%2.31B | 3.14%8.28B | 2.14%5.97B | 2.41%4.03B |
| Operating cost | -1.98%3.55B | -0.19%2.46B | -0.27%1.23B | 6.71%4.58B | 13.50%3.62B | 15.58%2.47B | 12.48%1.23B | 6.41%4.29B | 9.95%3.19B | 10.05%2.13B |
| Operating tax surcharges | 2.73%109.61M | 3.06%75.33M | 8.45%34.23M | 10.01%132.8M | 26.53%106.69M | 22.51%73.1M | 2.69%31.56M | 4.29%120.72M | -4.18%84.32M | -2.22%59.66M |
| Operating expense | 8.12%2.29B | 1.94%1.56B | 3.30%741.56M | -1.80%2.68B | 13.04%2.12B | 16.76%1.54B | 0.03%717.88M | -2.61%2.73B | -8.27%1.88B | -7.83%1.31B |
| Administration expense | 5.27%748.52M | 8.33%494.95M | -0.76%226.4M | 5.64%794.51M | 25.57%711.06M | 27.25%456.91M | 25.39%228.13M | 6.84%752.09M | -0.33%566.26M | 5.19%359.06M |
| Financial expense | 41.76%-25.23M | 15.70%-24.41M | -169.69%-13.67M | 54.23%-43.84M | 31.21%-43.32M | 9.51%-28.96M | 38.07%-5.07M | -159.49%-95.79M | -168.43%-62.97M | -122.41%-32.01M |
| -Interest expense (Financial expense) | -18.98%9.68M | -22.26%6.55M | -9.62%3.16M | 32.42%14.07M | 222.61%11.95M | 86.12%8.43M | 67.29%3.49M | -8.60%10.62M | -57.38%3.7M | -19.22%4.53M |
| -Interest Income (Financial expense) | 24.20%-35.64M | 5.01%-27.57M | -37.92%-15.89M | 40.98%-52.93M | 11.60%-47.02M | -8.10%-29.02M | 5.33%-11.52M | -64.76%-89.68M | -48.23%-53.18M | -15.06%-26.85M |
| Research and development | 14.33%472.69M | 24.34%328.65M | 17.06%130.33M | 16.37%561.46M | 30.34%413.44M | 36.61%264.32M | 33.29%111.34M | 17.80%482.48M | 19.07%317.2M | 7.24%193.49M |
| Credit Impairment Loss | 125.13%4.99M | 100.96%239.48K | -39.04%-23.62M | 27.11%-1.73M | 17.77%-19.84M | 9.15%-25.02M | -3.76%-16.99M | -84.19%-2.37M | -52.53%-24.12M | -53.49%-27.54M |
| Asset Impairment Loss | -16.38%-20.71M | 1,559.06%10M | 709.40%3.46M | -440.55%-101.7M | -302.12%-17.8M | 74.43%-685.62K | 127.33%427.85K | 71.16%-18.81M | -52.65%-4.43M | -0.37%-2.68M |
| Other net revenue | 85.73%189.21M | 106.41%141.55M | 25.16%4.13M | -102.14%-1.78M | 84.21%101.87M | 91.42%68.58M | -31.00%3.3M | 51.14%83.28M | -16.25%55.3M | 8.82%35.83M |
| Fair value change income | ---- | ---- | ---- | 130.45%13.8M | 2,416.81%11.01M | 2,148.38%6.98M | -51.83%2.85M | -83.06%5.99M | -98.41%437.52K | -101.57%-340.63K |
| Invest income | 73.37%126.91M | 70.01%79.94M | 227.68%12.77M | -22.69%12.55M | 175.54%73.2M | 132.69%47.02M | 4,348.54%3.9M | -40.14%16.23M | 111.90%26.57M | 697.13%20.21M |
| -Including: Investment income associates | 73.37%126.91M | ---- | 227.68%12.77M | -22.69%12.55M | 175.54%73.2M | ---- | 4,348.54%3.9M | 3.82%16.23M | 111.90%26.57M | 697.13%20.21M |
| Asset deal income | -12.62%480.9K | 128.06%2.04M | -52.71%319.75K | 97.53%-56.13K | 122.09%550.36K | -57.32%895.9K | 169.81%676.15K | -320.00%-2.27M | -155.60%-2.49M | 45.87%2.1M |
| Other revenue | 41.65%77.54M | 25.21%49.32M | -9.96%11.2M | -10.85%75.35M | -7.75%54.74M | -10.65%39.39M | -29.67%12.44M | 45.43%84.52M | 47.77%59.34M | 57.91%44.08M |
| Operating profit | -1.92%1.59B | 2.12%1.17B | 6.87%494.44M | 6.16%1.52B | 30.48%1.62B | 24.76%1.15B | 9.11%462.64M | 25.52%1.43B | 13.43%1.24B | 25.88%918.72M |
| Add:Non operating Income | 28.92%37.29M | 19.64%33.28M | 980.80%18.77M | 133.88%71.06M | 46.00%28.92M | 81.64%27.82M | 234.57%1.74M | 617.61%30.38M | 214.03%19.81M | 272.82%15.31M |
| Less:Non operating expense | 5.55%6.91M | -14.71%5.83M | 87.42%2.8M | -13.09%19.57M | -59.68%6.55M | -37.71%6.84M | -70.45%1.49M | 12.62%22.52M | 194.44%16.24M | 202.14%10.98M |
| Total profit | -1.40%1.62B | 2.63%1.2B | 10.27%510.42M | 9.17%1.57B | 31.90%1.64B | 26.45%1.17B | 10.35%462.88M | 27.98%1.43B | 13.68%1.24B | 26.39%923.06M |
| Less:Income tax cost | -19.90%205.58M | -15.02%144.4M | 32.87%105.71M | 19.55%240.61M | 15.69%256.67M | 9.40%169.93M | 7.32%79.56M | 35.03%201.27M | 30.66%221.86M | 44.17%155.33M |
| Add:Adjusted items effecting net profit | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- |
| Net profit | 2.03%1.41B | 5.64%1.05B | 5.58%404.71M | 7.48%1.33B | 35.42%1.38B | 29.90%997.27M | 11.00%383.33M | 26.90%1.23B | 10.56%1.02B | 23.31%767.73M |
| Net profit from continuing operation | 2.03%1.41B | 5.64%1.05B | 5.58%404.71M | 7.48%1.33B | 35.42%1.38B | 29.90%997.27M | 11.00%383.33M | 26.90%1.23B | 10.56%1.02B | 23.31%767.73M |
| Less:Minority Profit | 900.82%14.7M | -44.33%7M | -234.83%-11.4M | -113.29%-7.12M | -96.59%1.47M | -59.54%12.58M | -36.85%8.45M | 47.04%53.59M | 22.50%43.09M | 11.03%31.09M |
| Net profit of parent company owners | 1.07%1.4B | 6.28%1.05B | 11.00%416.11M | 12.96%1.33B | 41.24%1.38B | 33.67%984.69M | 12.92%374.88M | 26.12%1.18B | 10.08%978.68M | 23.89%736.64M |
| Earning per share | ||||||||||
| Basic earning per share | 0.83%1.3596 | 6.35%1.0199 | 11.01%0.4075 | 14.09%1.3002 | 41.43%1.3484 | 33.96%0.959 | 15.37%0.3671 | 27.06%1.1396 | 11.88%0.9534 | 25.60%0.7159 |
| Diluted earning per share | 0.83%1.3596 | 6.35%1.0199 | 10.93%0.405 | 14.09%1.3002 | 42.55%1.3484 | 33.96%0.959 | 14.74%0.3651 | 27.06%1.1396 | 11.00%0.9459 | 25.60%0.7159 |
| Other composite income | -103.06%-2.8K | -100.85%-781.09 | -101.53%-1.32K | -41.41%858.64K | 719.17%91.3K | 1,698.87%92.05K | 16,679.61%86.31K | 120.94%1.47M | 886.13%11.15K | 380.46%5.12K |
| Other composite income of parent company owners | -103.06%-2.8K | -100.85%-781.09 | -101.53%-1.32K | -53.18%858.44K | 719.17%91.3K | 1,698.87%92.05K | 16,679.61%86.31K | 128.00%1.83M | 886.13%11.15K | 380.46%5.12K |
| Other composite income of minority owners | ---- | ---- | ---- | 100.06%205.24 | ---- | ---- | ---- | 18.19%-367.98K | ---- | ---- |
| Total composite income | 2.02%1.41B | 5.63%1.05B | 5.55%404.71M | 7.42%1.33B | 35.43%1.38B | 29.91%997.36M | 11.02%383.42M | 27.97%1.24B | 10.56%1.02B | 23.31%767.73M |
| Total composite income of parent company owners | 1.07%1.4B | 6.27%1.05B | 10.97%416.11M | 12.86%1.33B | 41.24%1.38B | 33.69%984.78M | 12.95%374.96M | 27.20%1.18B | 10.08%978.69M | 23.89%736.64M |
| Total composite income of minority owners | 900.82%14.7M | -44.33%7M | -234.83%-11.4M | -113.38%-7.12M | -96.59%1.47M | -59.54%12.58M | -36.85%8.45M | 47.85%53.22M | 22.50%43.09M | 11.03%31.09M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
